Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study

Background Anti-thymocyte globulin (ATG) as induction therapy in renal transplantation is facing the dilemma of reducing the incidence of acute rejection (AR) and delayed graft function (DGF) or increasing risks of infection and malignancy. The purpose of this study was to delineate the safety and e...

Full description

Bibliographic Details
Main Authors: Hui-Ying Liu, Yuan-Tso Cheng, Hao Lun Luo, Chiang-Chi Huang, Chien Hsu Chen, Yuan-Chi Shen, Wen-Chin Lee
Format: Article
Language:English
Published: PeerJ Inc. 2019-08-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/7274.pdf